M. Strebelow

459 total citations
12 papers, 288 citations indexed

About

M. Strebelow is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, M. Strebelow has authored 12 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Surgery and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in M. Strebelow's work include Diabetes and associated disorders (11 papers), Pancreatic function and diabetes (10 papers) and Diabetes Management and Research (6 papers). M. Strebelow is often cited by papers focused on Diabetes and associated disorders (11 papers), Pancreatic function and diabetes (10 papers) and Diabetes Management and Research (6 papers). M. Strebelow collaborates with scholars based in Germany, United States and Australia. M. Strebelow's co-authors include Michael Schlosser, I Rjasanowski, M. Ziegler, B Ziegler, Ralf Waßmuth, Lisa K. Gilliam, J. Paul Banga, Ezio Bonifacio, Christiane S. Hampe and Dong Luo and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the New York Academy of Sciences and Diabetologia.

In The Last Decade

M. Strebelow

12 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Strebelow Germany 8 235 196 170 51 21 12 288
DA Heaton United Kingdom 6 324 1.4× 262 1.3× 246 1.4× 62 1.2× 34 1.6× 7 388
Paola Frongia Italy 8 204 0.9× 109 0.6× 118 0.7× 91 1.8× 31 1.5× 8 263
M.‐L. KÄÄR Finland 11 168 0.7× 84 0.4× 146 0.9× 52 1.0× 25 1.2× 14 310
K. S. Rønningen Norway 6 227 1.0× 149 0.8× 117 0.7× 65 1.3× 31 1.5× 7 274
Taylor M. Triolo United States 11 299 1.3× 218 1.1× 304 1.8× 46 0.9× 51 2.4× 23 449
Efisio Angius Italy 6 281 1.2× 169 0.9× 154 0.9× 135 2.6× 14 0.7× 7 327
Philip Bergman Australia 7 146 0.6× 107 0.5× 113 0.7× 53 1.0× 50 2.4× 14 244
A.-P. Laine Finland 6 375 1.6× 260 1.3× 252 1.5× 106 2.1× 16 0.8× 6 436
E. Sabbah Finland 10 724 3.1× 588 3.0× 573 3.4× 93 1.8× 24 1.1× 12 771
Sandra Lord United States 10 138 0.6× 125 0.6× 131 0.8× 22 0.4× 26 1.2× 18 218

Countries citing papers authored by M. Strebelow

Since Specialization
Citations

This map shows the geographic impact of M. Strebelow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Strebelow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Strebelow more than expected).

Fields of papers citing papers by M. Strebelow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Strebelow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Strebelow. The network helps show where M. Strebelow may publish in the future.

Co-authorship network of co-authors of M. Strebelow

This figure shows the co-authorship network connecting the top 25 collaborators of M. Strebelow. A scholar is included among the top collaborators of M. Strebelow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Strebelow. M. Strebelow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Struck, Joachim, M. Strebelow, Christine Alonso, et al.. (2009). Method for the Selective Measurement of Amino-Terminal Variants of Procalcitonin. Clinical Chemistry. 55(9). 1672–1679. 21 indexed citations
2.
Schlosser, Michael, Kerstin Koczwara, M. Strebelow, et al.. (2005). In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk. Diabetologia. 48(9). 1830–1832. 43 indexed citations
3.
Schlosser, Michael, J. Paul Banga, Anne‐Marie Madec, et al.. (2005). Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes. Diabetologia. 48(5). 922–930. 50 indexed citations
4.
Schlosser, Michael, M. Strebelow, I Rjasanowski, et al.. (2004). Prevalence of Diabetes‐Associated Autoantibodies in Schoolchildren: The Karlsburg Type 1 Diabetes Risk Study. Annals of the New York Academy of Sciences. 1037(1). 114–117. 22 indexed citations
5.
Schlosser, Michael, Ralf Waßmuth, M. Strebelow, I Rjasanowski, & M. Ziegler. (2003). Multiple and High‐Titer Single Autoantibodies in Schoolchildren Reflecting the Genetic Predisposition for Type 1 Diabetes. Annals of the New York Academy of Sciences. 1005(1). 98–108. 5 indexed citations
6.
Schlosser, Michael, M. Strebelow, Ralf Waßmuth, et al.. (2002). The Karlsburg Type 1 Diabetes Risk Study of a Normal Schoolchild Population: Association of β-Cell Autoantibodies and Human Leukocyte Antigen-DQB1 Alleles in Antibody-Positive Individuals. The Journal of Clinical Endocrinology & Metabolism. 87(5). 2254–2261. 35 indexed citations
7.
Strebelow, M., Michael Schlosser, B Ziegler, I Rjasanowski, & M. Ziegler. (1999). Karlsburg Type I diabetes risk study of a general population: frequencies and interactions of the four major Type I diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia. 42(6). 661–670. 67 indexed citations
8.
9.
Augstein, Petra, et al.. (1997). Immunohistochemical Differentiation of Monoclonal GAD Antibodies Recognizing Linear or Conformational Epitope Regions. Pancreas. 15(2). 139–146. 5 indexed citations
10.
11.
12.
Hamann, Jörg, et al.. (1994). A monoclonal antibody based enzyme-linked immunosorbent assay for the determination of GAD65, the smaller isoform of glutamic acid decarboxylase.. PubMed. 26(3). 109–16. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by DA Heaton Breakdown of academic impact, for papers by Paola Frongia Breakdown of academic impact, for papers by M.‐L. KÄÄR Breakdown of academic impact, for papers by K. S. Rønningen Breakdown of academic impact, for papers by Taylor M. Triolo Breakdown of academic impact, for papers by Efisio Angius Breakdown of academic impact, for papers by Philip Bergman Breakdown of academic impact, for papers by A.-P. Laine Breakdown of academic impact, for papers by E. Sabbah Breakdown of academic impact, for papers by Sandra Lord
Rankless by CCL
2026